As briefly highlighted above, this may be due to variations in cohort sizes or due to the variable nature of the samples tested, but nevertheless some very encouraging findings have emerged with regards to where (and to what extent) some cathepsins are expressed in tumor progression and what relationships they share with other prognostic protein markers. The gene discussed is CTSS; the disease is neoplasm.